Last update 01 Nov 2024

AD-218

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Mechanism-
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
DyslipidemiasHyperlipidemias
Inactive Indication-
Originator Organization
Addpharma, Inc.Addpharma, Inc.
Active Organization
Addpharma, Inc.Addpharma, Inc.
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AD-218
NCT05400317 / RecruitingPhase 3
A Randomized, Double-blinded, Active-controlled, Multicenter Phase 3 Clinical Trial and Open-label, Extension Study to Evaluate the Efficacy and Safety of AD-218 in Patients With Mixed Dyslipidemia
100 Clinical Results associated with AD-218
Login to view more data
100 Translational Medicine associated with AD-218
Login to view more data
100 Patents (Medical) associated with AD-218
Login to view more data
100 Deals associated with AD-218
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DyslipidemiasPhase 3
KR
Addpharma, Inc.Addpharma, Inc.
27 Jul 2022
HyperlipidemiasPhase 1
KR
Addpharma, Inc.Addpharma, Inc.
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free